$3.73
2.61% yesterday
Nasdaq, Sep 27, 10:00 pm CET
ISIN
CH1125843347
Symbol
SOPH

SOPHiA Genetics SA Target price 2024 - Analyst rating & recommendation

SOPHiA Genetics SA Classifications & Recommendation:

Buy
80%
Hold
20%

SOPHiA Genetics SA Price Target

Target Price $6.00
Price $3.73
Potential
Number of Estimates 4
4 Analysts have issued a price target SOPHiA Genetics SA 2025 . The average SOPHiA Genetics SA target price is $6.00. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 5 analysts: 4 Analysts recommend SOPHiA Genetics SA to buy, 1 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the SOPHiA Genetics SA stock has an average upside potential 2025 of . Most analysts recommend the SOPHiA Genetics SA stock at Purchase.

Sales and Margin forecast 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
Revenue Million $ 62.37 65.86
31.14% 5.60%
EBITDA Margin -109.94% -85.55%
37.69% 22.19%
Net Margin -129.51% -86.96%
31.60% 32.86%

5 Analysts have issued a sales forecast SOPHiA Genetics SA 2024 . The average SOPHiA Genetics SA sales estimate is

$65.9m
Unlock
. This is
1.42% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$66.1m 1.79%
Unlock
, the lowest is
$65.5m 0.91%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2023 $62.4m 31.14%
2024
$65.9m 5.60%
Unlock
2025
$79.4m 20.60%
Unlock
2026
$101m 27.56%
Unlock
2027
$118m 16.80%
Unlock
2028
$107m 9.59%
Unlock

4 Analysts have issued an SOPHiA Genetics SA EBITDA forecast 2024. The average SOPHiA Genetics SA EBITDA estimate is

$-56.3m
Unlock
. This is
8.96% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$-47.9m 22.60%
Unlock
, the lowest is
$-60.4m 2.42%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2023 $-68.6m 18.29%
2024
$-56.3m 17.82%
Unlock
2025
$-47.0m 16.66%
Unlock
2026
$-38.4m 18.29%
Unlock
2027
$-34.8m 9.31%
Unlock
2028
$-34.1m 2.01%
Unlock

EBITDA Margin

2023 -109.94% 37.69%
2024
-85.55% 22.19%
Unlock
2025
-59.12% 30.89%
Unlock
2026
-37.87% 35.94%
Unlock
2027
-29.40% 22.37%
Unlock
2028
-31.87% 8.40%
Unlock

2 SOPHiA Genetics SA Analysts have issued a net profit forecast 2024. The average SOPHiA Genetics SA net profit estimate is

$-57.3m
Unlock
. This is
15.20% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$-54.3m 19.61%
Unlock
, the lowest is
$-60.3m 10.79%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2023 $-80.8m 10.29%
2024
$-57.3m 29.10%
Unlock
2025
$-55.3m 3.46%
Unlock
2026
$-57.6m 4.18%
Unlock
2027
$-52.3m 9.18%
Unlock
2028
$-45.0m 13.94%
Unlock

Net Margin

2023 -129.51% 31.60%
2024
-86.96% 32.86%
Unlock
2025
-69.60% 19.96%
Unlock
2026
-56.85% 18.32%
Unlock
2027
-44.20% 22.25%
Unlock
2028
-42.08% 4.80%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
Earnings Per Share $ -1.22 -0.87
10.29% 28.69%
P/E negative
EV/Sales 2.56

2 Analysts have issued a SOPHiA Genetics SA forecast for earnings per share. The average SOPHiA Genetics SA <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is

$-0.87
Unlock
. This is
14.71% higher
Unlock
than earnings per share in the financial year 2023. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is
$-0.82 19.61%
Unlock
, the lowest is
$-0.91 10.78%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2023 $-1.22 10.29%
2024
$-0.87 28.69%
Unlock
2025
$-0.84 3.45%
Unlock
2026
$-0.87 3.57%
Unlock
2027
$-0.79 9.20%
Unlock
2028
$-0.68 13.92%
Unlock

P/E ratio

Current -3.65 87.18%
2024
-4.31 18.08%
Unlock
2025
-4.47 3.71%
Unlock
2026
-4.29 4.03%
Unlock
2027
-4.72 10.02%
Unlock
2028
-5.49 16.31%
Unlock

Based on analysts' sales estimates for 2024, the SOPHiA Genetics SA stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of

and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 2.60 441.67%
2024
2.56 1.59%
Unlock
2025
2.12 17.08%
Unlock
2026
1.66 21.61%
Unlock
2027
1.42 14.38%
Unlock
2028
1.58 10.61%
Unlock

P/S ratio

Current 3.76 31.13%
2024
3.70 1.40%
Unlock
2025
3.07 17.08%
Unlock
2026
2.41 21.61%
Unlock
2027
2.06 14.39%
Unlock
2028
2.28 10.61%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today